These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24325578)

  • 1. Synthesis and characterization of a novel series of agonist compounds as potential radiopharmaceuticals for imaging dopamine D₂/₃ receptors in their high-affinity state.
    van Wieringen JP; Shalgunov V; Janssen HM; Fransen PM; Janssen AG; Michel MC; Booij J; Elsinga PH
    J Med Chem; 2014 Jan; 57(2):391-410. PubMed ID: 24325578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PET.
    Shalgunov V; van Wieringen JP; Janssen HM; Fransen PM; Dierckx RA; Michel MC; Booij J; Elsinga PH
    J Nucl Med; 2015 Jan; 56(1):133-9. PubMed ID: 25476538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntheses and in vitro evaluation of fluorinated naphthoxazines as dopamine D2/D3 receptor agonists: radiosynthesis, ex vivo biodistribution and autoradiography of [(18)F]F-PHNO.
    Vasdev N; Seeman P; Garcia A; Stableford WT; Nobrega JN; Houle S; Wilson AA
    Nucl Med Biol; 2007 Feb; 34(2):195-203. PubMed ID: 17307127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET radiotracer development for imaging high-affinity state of dopamine D2 and D3 receptors: Binding studies of fluorine-18 labeled aminotetralins in rodents.
    Mukherjee J; Majji D; Kaur J; Constantinescu CC; Narayanan TK; Shi B; Nour MT; Pan ML
    Synapse; 2017 Mar; 71(3):. PubMed ID: 27864853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
    Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation in rats of homologous series of [(18)F]-labeled dopamine D 2/3 receptor agonists based on the 2-aminomethylchroman scaffold as potential PET tracers.
    Shalgunov V; van Wieringen JP; Janssen HM; Fransen PM; Dierckx RA; Michel MC; Booij J; Elsinga PH
    EJNMMI Res; 2015 Dec; 5(1):119. PubMed ID: 26205538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.
    Wilson AA; McCormick P; Kapur S; Willeit M; Garcia A; Hussey D; Houle S; Seeman P; Ginovart N
    J Med Chem; 2005 Jun; 48(12):4153-60. PubMed ID: 15943487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
    J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    Gackenheimer SL; Schaus JM; Gehlert DR
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occupancy of dopamine D2/3 receptors in rat brain by endogenous dopamine measured with the agonist positron emission tomography radioligand [11C]MNPA.
    Seneca N; Zoghbi SS; Skinbjerg M; Liow JS; Hong J; Sibley DR; Pike VW; Halldin C; Innis RB
    Synapse; 2008 Oct; 62(10):756-63. PubMed ID: 18651641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, pharmacological evaluation and molecular modeling studies of triazole containing dopamine D3 receptor ligands.
    Peng X; Wang Q; Mishra Y; Xu J; Reichert DE; Malik M; Taylor M; Luedtke RR; Mach RH
    Bioorg Med Chem Lett; 2015 Feb; 25(3):519-23. PubMed ID: 25556097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosynthesis and in vitro evaluation of 2-(N-alkyl-N-1'-11C-propyl)amino-5-hydroxytetralin analogs as high affinity agonists for dopamine D-2 receptors.
    Shi B; Narayanan TK; Yang ZY; Christian BT; Mukherjee J
    Nucl Med Biol; 1999 Oct; 26(7):725-35. PubMed ID: 10628551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of the binding of the dopamine D2 receptor agonist (11)C-(R,S)-5-hydroxy-2-(di-n-propylamino)tetralin in rodents and nonhuman primate.
    Mukherjee J; Narayanan TK; Christian BT; Shi B; Dunigan KA; Mantil J
    Synapse; 2000 Jul; 37(1):64-70. PubMed ID: 10842352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New generation dopaminergic agents. 1. Discovery of a novel scaffold which embraces the D2 agonist pharmacophore. Structure-activity relationships of a series of 2-(aminomethyl)chromans.
    Mewshaw RE; Kavanagh J; Stack G; Marquis KL; Shi X; Kagan MZ; Webb MB; Katz AH; Park A; Kang YH; Abou-Gharbia M; Scerni R; Wasik T; Cortes-Burgos L; Spangler T; Brennan JA; Piesla M; Mazandarani H; Cockett MI; Ochalski R; Coupet J; Andree TH
    J Med Chem; 1997 Dec; 40(26):4235-56. PubMed ID: 9435894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventral striatum binding of a dopamine D2/3 receptor agonist but not antagonist predicts normal body mass index.
    Caravaggio F; Raitsin S; Gerretsen P; Nakajima S; Wilson A; Graff-Guerrero A
    Biol Psychiatry; 2015 Jan; 77(2):196-202. PubMed ID: 23540907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro.
    McCormick PN; Kapur S; Reckless G; Wilson AA
    Synapse; 2009 Nov; 63(11):998-1009. PubMed ID: 19598174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of the binding of dopamine D2/D3 receptor agonist, (R,S)-5-hydroxy-2-(N-propyl-N-(5'-(18)F-fluoropentyl)aminotetralin ((18)F-5-OH-FPPAT) in rodents and nonhuman primates.
    Shi B; Narayanan TK; Christian BT; Chattopadhyay S; Mukherjee J
    Nucl Med Biol; 2004 Apr; 31(3):303-11. PubMed ID: 15028242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro and In Vivo Identification of Novel Positive Allosteric Modulators of the Human Dopamine D2 and D3 Receptor.
    Wood M; Ates A; Andre VM; Michel A; Barnaby R; Gillard M
    Mol Pharmacol; 2016 Feb; 89(2):303-12. PubMed ID: 26655303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acutely administered antipsychotic drugs are highly selective for dopamine D2 over D3 receptors.
    McCormick PN; Wilson VS; Wilson AA; Remington GJ
    Pharmacol Res; 2013 Apr; 70(1):66-71. PubMed ID: 23327779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain uptake and distribution of the dopamine D3 /D2 receptor partial agonist [11 C]cariprazine: an in vivo positron emission tomography study in nonhuman primates.
    Tóth M; Varrone A; Steiger C; Laszlovszky I; Horváth A; Kiss B; Gyertyán I; Adham N; Halldin C; Gulyás B
    Synapse; 2013 May; 67(5):258-64. PubMed ID: 23238770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.